Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Progenitor Cells”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)WithdrawnNCT03058068
What this trial is testing

Human MesenchymAl Stem Cells Infusion in Patients With Cystic Fibrosis

Who this might be right for
Cystic Fibrosis
Joshua M Hare
Not applicableLooking for participantsNCT06468618
What this trial is testing

Developing Restful Environments and Management Strategies for Pediatric Stem Cell Transplant Patients

Who this might be right for
Stem Cell Transplant ComplicationsSleep Disturbance
Dana-Farber Cancer Institute 10
Large-scale testing (Phase 3)Ended earlyNCT01339910
What this trial is testing

Reduced Intensity Regimen vs Myeloablative Regimen for Myeloid Leukemia or Myelodysplastic Syndrome (BMT CTN 0901)

Who this might be right for
Leukemia, Myelocytic, Acute
Medical College of Wisconsin 272
Not applicableUnknownNCT05165459
What this trial is testing

Open Label Single Arm Proof of Concept Trial to Evaluate the Efficacy and Safety of Cytori Celution System in Chronic Non-Healing Venous Leg Ulcers

Who this might be right for
Venous Leg UlcerAutologous Adipose Stromal Vascular FractionAdipose-Derived Mesenchymal Stem Cells+1 more
Szeged University 10
Testing effectiveness (Phase 2)Study completedNCT01341262
What this trial is testing

THAL-DEX Incorporated Into Double PBSC Autotransplantation for Untreated Multiple Myeloma (MM)

Who this might be right for
Multiple Myeloma
IRCCS Azienda Ospedaliero-Universitaria di Bologna 378
Early research (Phase 1)Study completedNCT00586690
What this trial is testing

Safety Trial of NK DLI From 6/6 HLA Matched Family Member Following Nonmyeloablative ASCT

Who this might be right for
Lymphoma
David Rizzieri, MD 47
Testing effectiveness (Phase 2)Study completedNCT00556127
What this trial is testing

Rituximab in Addition to Chemotherapy With Autologous Stem Cell Transplantation as Treatment Diffuse Large B-Cell Lymphoma

Who this might be right for
Diffuse Large B-Cell LymphomaPOOR PROGNOSIS
Gruppo Italiano Multiregionale per lo studio dei Linfomi e delle Leucemie 94
Early research (Phase 1)UnknownNCT05227846
What this trial is testing

Human Umbilical Cord-derived Mesenchymal Stem Cells for Decompensated Cirrhosis (MSC-DLC-1)

Who this might be right for
Decompensated Cirrhosis
Beijing 302 Hospital 12
Not applicableEnded earlyNCT01071577
What this trial is testing

Collection of Bone Marrow From Healthy Volunteers and Patients for the Production of Clinical Bone Marrow Stromal Cell (BMSC) Products

Who this might be right for
Bone Marrow Stromal Cells
National Institutes of Health Clinical Center (CC) 65
Very early researchUnknownNCT03765957
What this trial is testing

Clinical Research on Treatment of Psoriasis by Human Umbilical Cord-derived Mesenchymal Stem Cells

Who this might be right for
Psoriasis
Central South University 12
Testing effectiveness (Phase 2)Looking for participantsNCT07693036
What this trial is testing

HUC-MSC-Exosomes for T2DM - Safety & Efficacy

Who this might be right for
Type 2 Diabetes Mellitus (T2DM)
Peking University First Hospital 66
Not applicableStudy completedNCT03183934
What this trial is testing

A Follow-up Study to Evaluate the Efficacy and Safety of ALLO-ASC-DFU in ALLO-ASC-EB-101 Clinical Trial

Who this might be right for
Dystrophic Epidermolysis Bullosa
Anterogen Co., Ltd. 2
Testing effectiveness (Phase 2)Study completedNCT00435084
What this trial is testing

A Phase I/II Study to Assess the Safety and Tolerability of APO866 for the Treatment of Refractory B-CLL

Who this might be right for
B-cell Chronic Lymphocytic Leukemia
Valerio Therapeutics 10
Testing effectiveness (Phase 2)UnknownNCT05120700
What this trial is testing

Synovial Tissue and Fat Pad Stromal Vascular Fraction Bioengineering in Patients With Knee Articular Cartilage Injury

Who this might be right for
Cell- and Tissue-Based TherapyCartilage InjuryKnee Injuries
University of Sao Paulo General Hospital 10
Testing effectiveness (Phase 2)WithdrawnNCT03982992
What this trial is testing

Allogeneic Donor Lymphocyte Infusions Combined With Blinatumomab

Who this might be right for
B Cell Precursor Acute Lymphoblastic Leukemia With Mixed Chimerism or Minimal Residual Disease After Allogeneic Stem Cell TransplantationB-Cell Acute Lymphoblastic LeukemiaAcute Lymphoblastic Leukemia+2 more
Ludwig-Maximilians - University of Munich
Testing effectiveness (Phase 2)Study completedNCT01469832
What this trial is testing

Safety and Tolerability of Sub-retinal Transplantation of Human Embryonic Stem Cell Derived Retinal Pigmented Epithelial (hESC-RPE) Cells in Patients With Stargardt's Macular Dystrophy (SMD)

Who this might be right for
Stargardt's Macular Dystrophy
Astellas Institute for Regenerative Medicine 12
Not applicableStudy completedNCT05243498
What this trial is testing

Allogenomic Mismatch Score (AMS) Applied to Haplo-identical Donor/Recipient Pairs in Haematopoietic Stem Cell Transplantation

Who this might be right for
Stem Cell TransplantationHaplo-identical
Central Hospital, Nancy, France 80
Not applicableStudy completedNCT01897987
What this trial is testing

Follow-up Safety and Efficacy Evaluation on Subjects Who Completed PNEUMOSTEM® Phase-II Clinical Trial

Who this might be right for
Bronchopulmonary Dysplasia
Medipost Co Ltd. 62
Testing effectiveness (Phase 2)Study completedNCT01660581
What this trial is testing

Intracardiac CD133+ Cells in Patients With No-option Resistant Angina

Who this might be right for
Stable Angina
Medical University of Silesia 31
Testing effectiveness (Phase 2)Study completedNCT02572167
What this trial is testing

Brentuximab Vedotin Combined With Nivolumab for Relapsed or Refractory Hodgkin Lymphoma

Who this might be right for
Hodgkin Lymphoma
Seagen Inc. 93
Next Page